search

Active clinical trials for "Lung Neoplasms"

Results 1691-1700 of 6521

Real World Registry for Use of the Ion Endoluminal System

Lung CancerMultiple Pulmonary Nodules7 more

The primary objective of this study is to evaluate the performance of the Ion Endoluminal System with real-world use for pulmonary lesion localization or biopsy.

Recruiting7 enrollment criteria

Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell...

Non-Small Cell Lung CancerSmall Cell Lung Cancer3 more

Background: - Lung cancer is the leading cause of cancer-related death worldwide. It causes more than one million deaths every year. Researchers want to gather tissue samples from people with lung and thymic cancers to understand the disease better. This may lead to new ways to diagnose and treat it. Objective: - To collect tissue samples for use in the study of lung cancers. Eligibility: - Adults over age 18 with non-small cell lung cancer, small cell lung cancer, extra pulmonary small cell cancer, pulmonary neuroendocrine tumors, and thymic epithelial tumors. Design: Participants will be screened with a medical history, physical exam, and blood tests. They will be asked about how they perform their daily tasks. Participants may be asked to give urine and blood samples. They may give a saliva sample if they cannot give blood. They will also give a sample of their tumor from a biopsy they had. They may also be given the option to undergo a biopsy. Participants may have MRI, CT, and/or PET scans of the body. They will lie in a machine that takes pictures of the body. After visits to the Clinical Center end, researchers will contact participants by phone every year to check on their health.

Recruiting8 enrollment criteria

Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung...

Metastatic Non-small Cell Lung Cancer (NSCLC)Non-small Cell Lung Cancer Metastatic4 more

Open, non-interventional, prospective, multi-center clinical research platform with the main objective to assess molecular biomarker testing, treatment and outcome of patients with NSCLC or SCLC in Germany

Recruiting18 enrollment criteria

Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma

CarcinomaSquamous Cell13 more

The study will utilize both retrospective and prospective data collection from patients that already had a bronchoscopy and lung resection or will have a bronchoscopy and lung resection for squamous cell carcinoma. The investigators plan to prospectively collect 5 bronchoscopic biopsies, 10ml blood and one tumor and adjacent normal samples from 200 qualified patients who meet the study criteria.

Recruiting6 enrollment criteria

Identification of Predictive and Prognostic Markers for Lung Cancer With Metastases

Lung CancerPrimary Tumor1 more

The project aims to compare the histopathological and molecular characteristics of tumour tissue from metastases with similar analyses of the primary tumour in the lung, where it is available. The investigators will therefore perform analysis of blood samples if possible, to identify predictive markers in blood samples.

Active5 enrollment criteria

Establishment of a Tumor Bank for Blood Samples

Ovarian NeoplasmsBreast Neoplasms4 more

Establishment of a tumor bank, consisting of blood samples of tumor patients and healthy people as controls. The blood samples will be collected systematically together with the corresponding clinical data. The biological samples, the clinical date together with prospective experimental date constitute the entity of the tumor bank.

Recruiting8 enrollment criteria

Excretion of Acetylamantadine (AA) by Lung Cancer Patients During a Chemotherapy Regimen

Lung Cancer

This study is designed to determine if changes in acetyl amantadine (AA) metabolism with systemic chemotherapy - reflective of SSAT1 activity - are predictive of response to systemic therapy in patients with lung cancer. Ten patients with adenocarcinoma and 10 with small-cell cancer who are at American Joint Committee on Cancer (AJCC) stages 3 or 4 at the time of diagnosis will participate. AA metabolites will be examined by ELISA prior to initiation of systemic chemotherapy and after the second cycle of therapy. Changes in the pattern of metabolites will be correlated with convention clinical and radiographic response criteria.

Recruiting9 enrollment criteria

The Efficacy of Shear-wave Elastography-guided Aspiration and Biopsy for Diagnosis in Lung Tumor...

Lung Tumor

To use the shear-wave elastography to assist the transthoracic ultrasound-guided aspiration biopsy of peripheral lung tumor To identify the intra-tumor heterogeneity of elasticity To increase the diagnostic yield in ultrasound-guided transthoracic biopsy of subpleural pulmonary tumor

Active4 enrollment criteria

International Lung Screen Trial (ILST)

Non-small Cell Lung CancerLung Neoplasms7 more

People who may be at increased risk of lung cancer due to age and smoking history will be invited to participate in this international study to determine the best way of using computed tomography (CT) of the chest to screen for early lung cancer. Overseas data show that CT screening (screening tests can find diseases early, when they're easier to treat) can reduce deaths from lung cancer and this study will help determine who is most likely benefit from screening.

Active17 enrollment criteria

Integrative Analysis of Large-cell Lung Cancer

Lung Cancer

Integrative analysis of LCLC

Recruiting8 enrollment criteria
1...169170171...653

Need Help? Contact our team!


We'll reach out to this number within 24 hrs